This presentation aims to provide an overview of methods currently used for interpretation of germline variants in TP53 and other hereditary cancer genes, providing comparison between ACMG codes and information types used in quantitative classification models. It will also provide specific examples of how data can be mined to determine the applicability and weight of evidence codes for specific genes.